Total planned funding: $271,793,599
Allocations
Countries/Regions
Eswatini | $271,793,599 |
Organizational Types
Private Contractor | $68,341,050 |
Unknown | $54,785,765 |
NGO | $46,581,674 |
University | $45,721,644 |
Own Agency | $32,925,983 |
Host Country Government Agency | $7,025,705 |
Multi-lateral Agency | $6,388,202 |
FBO | $6,156,276 |
Other USG Agency | $3,277,300 |
Implementing Agency | $590,000 |
Program Areas
Treatment | $79,347,190 |
Care | $72,114,856 |
Prevention | $55,410,296 |
Governance and Systems | $27,661,257 |
Management and Operations | $21,407,738 |
Testing | $15,852,262 |
Budget Codes
HTXS: Treatment: Adult Treatment | $64,119,796 |
HBHC: Care: Adult Care and Support | $28,713,720 |
HKID: Care: Orphans and Vulnerable Children | $26,408,673 |
HVMS: Management and Operations | $21,407,738 |
HVOP: Sexual Prevention: Other Sexual Prevention | $20,040,674 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $17,787,060 |
HVCT: Testing: HIV Testing and Counseling | $15,852,262 |
HVSI: Strategic Information | $12,238,875 |
HVTB: Care: TB/HIV | $11,851,565 |
OHSS: Health Systems Strengthening | $10,926,384 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $9,483,042 |
HTXD: Treatment: ARV Drugs | $9,083,563 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,697,734 |
PDTX: Treatment: Pediatric Treatment | $6,143,831 |
PDCS: Care: Pediatric Care and Support | $5,140,898 |
HLAB: Laboratory Infrastructure | $4,495,998 |
HMBL: Biomedical Prevention: Blood Safety | $401,786 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Not Available:
$40,221,898
Countries/Regions
Columbia University:
$39,173,518
Countries/Regions
Pact, Inc.:
$32,874,374
Countries/Regions
USG Aggregated Agencies:
$18,038,713
Countries/Regions
Chemonics International:
$16,968,855
Countries/Regions